---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-265516"
form_type: "8-K"
ticker: "THC"
cik: "0000070318"
company_name: "TENET HEALTHCARE CORP"
filed_at: "2021-09-03T23:59:59+00:00"
generated_at: "2026-06-29T05:55:26.506467+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tenet Healthcare CEO transition: Rittenmeyer to Executive Chairman, Sutaria becomes CEO Sept 1, 2021

## Summary
- Ronald Rittenmeyer transitions from CEO to Executive Chairman through 2022, then advisor through 2024; base salary $1.5M then $750K, retention bonus $5M.
- Saumya Sutaria promoted to CEO effective Sept 1, 2021; base salary $1.2M, target bonus 125% of salary, equity award $8M in RSUs.
- Sutaria's employment agreement initial term through Dec 31, 2025, with automatic one-year renewals; severance provisions detailed.
- Rittenmeyer receives $5M retention bonus payable Dec 31, 2024 if employed through Term; accelerated vesting on qualifying termination.
- Both executives subject to perpetual confidentiality, non-disparagement, and post-employment non-compete/non-solicit covenants.

## SEC filing metadata
- accession: 0001193125-21-265516
- form_type: 8-K
- ticker: THC
- cik: 0000070318
- company_name: TENET HEALTHCARE CORP
- filed_at: 2021-09-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/0001193125-21-265516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/d268536d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-265516
- JSON: https://secwatch.observer/filing/0001193125-21-265516.json
- Plain text: https://secwatch.observer/filing/0001193125-21-265516.txt

## Key facts
- Executive change
  Ronald A. Rittenmeyer changed role as Executive Chairman at TENET HEALTHCARE CORP.
  - Action: transitioned
  - Role: Executive Chairman
  source text: Ronald A. Rittenmeyer will transition from Chief Executive Officer of the Company and continue as the Executive Chairman of the Company and the Company’s board of directors (the “ Board ”) through 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/0001193125-21-265516-index.htm
- Executive change
  Saumya Sutaria, M.D. changed role as Chief Executive Officer at TENET HEALTHCARE CORP.
  - Action: promoted
  - Role: Chief Executive Officer
  source text: Saumya Sutaria, M.D., will be promoted from President and Chief Operating Officer of the Company to Chief Executive Officer of the Company, in each case effective as of September 1, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/0001193125-21-265516-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.